Comparative Pharmacology
Head-to-head clinical analysis: BENICAR HCT versus VALSARTAN HYDROCHLOROTHIAZIDE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: BENICAR HCT versus VALSARTAN HYDROCHLOROTHIAZIDE.
BENICAR HCT vs VALSARTAN; HYDROCHLOROTHIAZIDE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Combination of an angiotensin II receptor blocker (ARB) and a thiazide diuretic. Olmesartan blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin II by selectively antagonizing the AT1 receptor. Hydrochlorothiazide inhibits the sodium-chloride symporter in the distal convoluted tubule, increasing excretion of sodium, chloride, and water, thereby reducing plasma volume.
Valsartan is an angiotensin II receptor blocker (ARB) that selectively blocks the binding of angiotensin II to the AT1 receptor, leading to vasodilation and reduced aldosterone secretion. Hydrochlorothiazide is a thiazide diuretic that inhibits the sodium-chloride symporter in the distal convoluted tubule, increasing excretion of sodium and water.
One tablet orally once daily. Available strengths: 40 mg olmesartan / 12.5 mg hydrochlorothiazide, 40 mg olmesartan / 25 mg hydrochlorothiazide. Dose may be titrated after 2-4 weeks based on response.
80-320 mg valsartan / 12.5-25 mg hydrochlorothiazide once daily orally, titrated based on blood pressure response.
None Documented
None Documented
Olmesartan: Terminal elimination half-life is 10-15 hours, supporting once-daily dosing. Hydrochlorothiazide: Terminal half-life is 5.6-14.8 hours (mean ~10 hours), prolonged in renal impairment.
Valsartan: terminal half-life is approximately 6 hours. Hydrochlorothiazide: terminal half-life ranges from 5.6 to 14.8 hours, with an average of about 8 hours; prolonged in renal impairment.
Olmesartan: Approximately 50-65% of absorbed dose excreted in urine (10-20% as unchanged drug, remainder as metabolites), 35-50% in feces via biliary excretion. Hydrochlorothiazide: ≥95% excreted renally as unchanged drug.
Valsartan: primarily excreted unchanged in feces (70%) via biliary elimination, with renal excretion accounting for about 30% (mostly unchanged). Hydrochlorothiazide: eliminated by renal excretion, with approximately 95% of the absorbed dose excreted unchanged in urine via tubular secretion.
Category C
Category D/X
ARB + Thiazide Diuretic
ARB